Jnl Series Trust · net assets $2.68B · 142 holdings as of June 30, 2026. Monthly N-PORT disclosure: the full book, not just equities.
EC: 99.5% · STIV: 0.4% · DE: 0.0%
| Month 1 | Month 2 | Month 3 | |
|---|---|---|---|
| Sales | $22.8M | $25.8M | $46.1M |
| Reinvestment | $0 | $0 | $0 |
| Redemptions | $68M | $56.5M | $72.8M |
| Net realized gain (non-derivative) | $12.3M | $23.2M | $25.9M |
| Net unrealized appreciation (non-derivative) | $-21.9M | $37.7M | $144M |
The three months of the reporting period, as filed; month 3 ends June 30, 2026.
| Holding | Value | % of net assets |
|---|---|---|
| Eli Lilly And Company EC | $396M | 14.77% |
| Johnson & Johnson EC | $252M | 9.41% |
| Abbvie Inc. EC | $183M | 6.84% |
| Unitedhealth Group Incorporated EC | $155M | 5.79% |
| Merck & Co., Inc. EC | $127M | 4.75% |
| Amgen Inc. EC | $80.2M | 2.99% |
| Thermo Fisher Scientific Inc. EC | $76.8M | 2.87% |
| Abbott Laboratories EC | $65M | 2.43% |
| Gilead Sciences, Inc. EC | $64.6M | 2.41% |
| Intuitive Surgical, Inc. EC | $57.8M | 2.16% |
| Pfizer Inc. EC | $56.2M | 2.10% |
| Cvs Health Corporation EC | $53.9M | 2.01% |
| Vertex Pharmaceuticals Incorporated EC | $51.9M | 1.94% |
| Danaher Corporation EC | $50.6M | 1.89% |
| Bristol-myers Squibb Company EC | $48.3M | 1.80% |
| Stryker Corporation EC | $46.9M | 1.75% |
| Medtronic, Inc. EC | $41.3M | 1.54% |
| Mckesson Corporation EC | $37.4M | 1.40% |
| Elevance Health, Inc. EC | $33.3M | 1.24% |
| Cigna Group, The EC | $28.9M | 1.08% |
| Boston Scientific Corporation EC | $26M | 0.97% |
| Regeneron Pharmaceuticals, Inc. EC | $25.9M | 0.97% |
| Hca Healthcare, Inc. EC | $24.2M | 0.90% |
| Cardinal Health, Inc. EC | $22.9M | 0.86% |
| Cencora, Inc. EC | $22.5M | 0.84% |
| Edwards Lifesciences Corporation EC | $20.7M | 0.77% |
| Humana Inc. EC | $19.7M | 0.73% |
| Becton, Dickinson And Company EC | $17.2M | 0.64% |
| Alnylam Pharmaceuticals, Inc. EC | $16.5M | 0.61% |
| Idexx Laboratories, Inc. EC | $16.4M | 0.61% |
| Agilent Technologies, Inc. EC | $15.6M | 0.58% |
| Natera, Inc. EC | $15.3M | 0.57% |
| Waters Corporation EC | $15.1M | 0.57% |
| Revolution Medicines, Inc. EC | $14.2M | 0.53% |
| Iqvia Holdings Inc EC | $13.1M | 0.49% |
| Biogen Inc. EC | $13.1M | 0.49% |
| Centene Corporation EC | $13M | 0.49% |
| Zoetis Inc. EC | $12.4M | 0.46% |
| Ge Healthcare Technologies Inc. EC | $12M | 0.45% |
| Resmed Inc. EC | $11.7M | 0.44% |
| Illumina, Inc. EC | $11M | 0.41% |
| Veeva Systems Inc. EC | $10.9M | 0.41% |
| Dexcom, Inc. EC | $10.7M | 0.40% |
| Mettler-toledo International Inc. EC | $10.7M | 0.40% |
| West Pharmaceutical Services, Inc. EC | $10.4M | 0.39% |
| Moderna, Inc. EC | $10.2M | 0.38% |
| Jnl Government Money Market Fund STIV | $9.75M | 0.36% |
| Quest Diagnostics Incorporated EC | $9.66M | 0.36% |
| Labcorp Holdings Inc. EC | $9.45M | 0.35% |
| Insmed Incorporated EC | $9.43M | 0.35% |
| Steris Public Limited Company EC | $8.57M | 0.32% |
| Royalty Pharma PLC EC | $8.53M | 0.32% |
| United Therapeutics Corporation EC | $8.42M | 0.31% |
| Guardant Health, Inc. EC | $7.86M | 0.29% |
| Incyte Corporation EC | $7.82M | 0.29% |
| Viatris Inc. EC | $7.38M | 0.28% |
| Roivant Sciences Ltd. EC | $7.29M | 0.27% |
| Neurocrine Biosciences, Inc. EC | $6.94M | 0.26% |
| Zimmer Biomet Holdings, Inc. EC | $6.88M | 0.26% |
| Tenet Healthcare Corporation EC | $6.59M | 0.25% |
Showing top 60 of 142 holdings.
Loading...
